Frontiers in endocrinology, 12, 645563
Current Research Limitations and What We Still Don't Know Most evidence linking GLP-1 medications to smoking reduction comes from case reports, small observational studies, and post-hoc analyses rather than randomized controlled trials designed specifically for smoking cessation
Seal, I., Sil, S., Das, A., & Roy, S
Provider Information Specialties Dermatology Gender Male Languages English Gujarati Age groups seen Adults Geriatrics Education USF College of Medicine Residency, Dermatology USF College of Medicine Internship, Internal Medicine USF College of Medicine Medical School Georgetown University Graduate, Physiology University of Florida College of Medicine Undergraduate, Psychology Certifications American Board of Dermatology - Dermatology American Board of Preventive Medicine - Clinical Informatics American Board of Preventive Medicine - Clinical Informatics, 2022 NPI 1053630764 Verified Reviews The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey
Fiscal Impact of Expanded Medicare Coverage for GLP-1 Receptor Agonists to Treat Obesity was published in JAMA Health Forum in April 2025